476 results match your criteria: "Centre d'immunologie et des maladies infectieuses Cimi[Affiliation]"

Author Correction: Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers.

Nat Commun

May 2021

Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Assistance Publique-Hôpitaux de Paris (AP-HP), Pitié Salpêtrière Hospital, Department of Virology, Paris, France.

View Article and Find Full Text PDF

Sampling strategy for bacteriological diagnosis of intrathoracic tuberculosis.

Respir Med Res

May 2021

Laboratoire de bactériologie-hygiène, centre national de référence des mycobactéries et de la résistance des mycobactéries aux antituberculeux, groupe hospitalier, Sorbonne Université, Site Pitié-Salpêtrière, AP-HP, Paris, France; Inserm U1135, Sorbonne université, centre d'immunologie et des maladies infectieuses (CIMI-Paris), Paris, France; Département de bactériologie, groupe hospitalier, Sorbonne université, site Saint-Antoine, AP-HP, Paris, France.

Background: Pulmonary tuberculosis (TB) is the most frequent site of TB and the one leading its spread worldwide. Multiple specimens are commonly collected for TB diagnosis including those requiring invasive procedures. This study aimed to review the sampling strategy for the microbiological diagnosis of pulmonary TB.

View Article and Find Full Text PDF

Impact of the revised definition of extensively drug-resistant tuberculosis.

Eur Respir J

August 2021

Centre d'Immunologie et des Maladies Infectieuses (Cimi-Paris), UMR 1135, Laboratoire de Bactériologie-Hygiène, Hôpital Pitié-Salpêtrière, Centre National de Référence des Mycobactéries, APHP, Sorbonne Université, Sorbonne Université, Paris, France.

View Article and Find Full Text PDF

Natural Killer Cells in Post-Transplant Lymphoproliferative Disorders.

Cancers (Basel)

April 2021

Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), INSERM U1135, CNRS ERL8285, Sorbonne Université, Hôpital Pitié-Salpêtrière, 75013 Paris, France.

Post-transplant lymphoproliferative disorders (PTLDs) are life-threatening complications arising after solid organ or hematopoietic stem cell transplantations. Although the majority of these lymphoproliferations are of B cell origin, and are frequently associated with primary Epstein-Barr virus (EBV) infection or reactivation in the post-transplant period, rare cases of T cell and natural killer (NK) cell-originated PTLDs have also been described. A general assumption is that PTLDs result from the impairment of anti-viral and anti-tumoral immunosurveillance due to the long-term use of immunosuppressants in transplant recipients.

View Article and Find Full Text PDF

Immune activation and chronic inflammation: Is there an additional effect of HIV in a geriatric population?

Medicine (Baltimore)

April 2021

Department of Infectious Diseases, Hôtel Dieu CHU Nantes, INSERM UIC 1413, CHU Nantes, France.

HIV infection has become a chronic disease, with a lower mortality, but a consequent increase in age-related noninfectious comorbidities. Metabolic disorders have been linked to the effect of cART as well to the effects of immune activation and chronic inflammation. Whereas it is known that aging is intrinsically associated with hyperinflammation and immune system deterioration, the relative impact of chronic HIV infection on such inflammatory and immune activation has not yet been studied focusing on an elderly HIV-infected population.

View Article and Find Full Text PDF

Sustained high expression of multiple APOBEC3 cytidine deaminases in systemic lupus erythematosus.

Sci Rep

April 2021

Molecular Retrovirology Unit, UMR 3569, Institut Pasteur, CNRS, 28 rue du Dr. Roux, 75724, Paris cedex 15, France.

Article Synopsis
  • APOBEC3 enzymes, particularly A3A and A3B, are significantly upregulated in patients with Systemic Lupus Erythematosus (SLE), especially during disease flares and with high levels of interferon-α (IFN-α).
  • This upregulation, observed in a study of 57 SLE patients, was found in 14.9% of patients with a specific genetic polymorphism that enhances A3A, and it correlates with cellular DNA damage and low lymphocyte counts.
  • The findings suggest that high levels of A3A and A3B may promote cell death and inflammation in SLE, indicating that targeting these enzymes might help alleviate symptoms and reduce the formation
View Article and Find Full Text PDF

CD4Foxp3 regulatory T (Treg) cells are central modulators of autoimmune diseases. However, the timing and location of Treg cell-mediated suppression of tissue-specific autoimmunity remain undefined. Here, we addressed these questions by investigating the role of tumor necrosis factor (TNF) receptor 2 (TNFR2) signaling in Treg cells during experimental autoimmune encephalomyelitis (EAE), a model of multiple sclerosis.

View Article and Find Full Text PDF

EBV-positive and EBV-negative posttransplant lymphoproliferative disorders (PTLDs) arise in different immunovirological contexts and might have distinct pathophysiologies. To examine this hypothesis, we conducted a multicentric prospective study with 56 EBV-positive and 39 EBV-negative PTLD patients of the K-VIROGREF cohort, recruited at PTLD diagnosis and before treatment (2013-2019), and compared them to PTLD-free Transplant Controls (TC, n = 21). We measured absolute lymphocyte counts (n = 108), analyzed NK- and T cell phenotypes (n = 49 and 94), and performed EBV-specific functional assays (n = 16 and 42) by multiparameter flow cytometry and ELISpot-IFNγ assays (n = 50).

View Article and Find Full Text PDF

Plasma Exchange to Rescue Patients with Autoantibodies Against Type I Interferons and Life-Threatening COVID-19 Pneumonia.

J Clin Immunol

April 2021

Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Médecine Intensive Réanimation, AP-HP and INSERM UMRS_1166-iCAN, Institute of Cardiometabolism and Nutrition, Paris, France.

Purpose: To report four cases of life-threatening COVID-19 pneumonia in patients with high blood concentrations of neutralizing autoantibodies against type I interferons (IFNs), who were treated with plasma exchange (PE) as a rescue therapy.

Methods: Prospective case series, which included patients, diagnosed with RT-PCR-confirmed SARS-CoV-2 infection and positive autoantibodies against type I IFNs in two French intensive care units (ICUs) between October 8 and November 14, 2020. Six critically ill COVID-19 patients with no anti-IFN antibodies were used as controls.

View Article and Find Full Text PDF

[Rethinking the place of B lymphocyte and tertiary lymphoid structures in oncoimmunotherapy].

Med Sci (Paris)

February 2021

Laboratoire Microenvironnement immunitaire et immunothérapie, UMRS 1135 Sorbonne Université, Inserm U1135, Centre d'immunologie et des maladies infectieuses (CIMI-Paris), Faculté de médecine Sorbonne Université, 91 boulevard de l'Hôpital, 75013 Paris, France.

View Article and Find Full Text PDF

We report a multicentric retrospective case series of patients with COVID-19 who developed acute kidney injury and/or proteinuria and underwent a kidney biopsy in the Paris and its metropolitan area. Forty-seven patients (80.9% men) with COVID-19 who underwent a kidney biopsy between March 08 and May 19, 2020 were included.

View Article and Find Full Text PDF

Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers.

Nat Commun

February 2021

Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Assistance Publique-Hôpitaux de Paris (AP-HP), Pitié Salpêtrière Hospital, Department of Virology, Paris, France.

There are only few data concerning persistence of neutralizing antibodies (NAbs) among SARS-CoV-2-infected healthcare workers (HCW). These individuals are particularly exposed to SARS-CoV-2 infection and at potential risk of reinfection. We followed 26 HCW with mild COVID-19 three weeks (D21), two months (M2) and three months (M3) after the onset of symptoms.

View Article and Find Full Text PDF

Objective: The intestinal epithelial barrier (IEB) restricts the passage of microbes and potentially harmful substances from the lumen through the paracellular space, and rupture of its integrity is associated with a variety of gastrointestinal disorders and extra-digestive diseases. Increased IEB permeability has been linked to disruption of metabolic homeostasis leading to obesity and type 2 diabetes. Interestingly, recent studies have uncovered compelling evidence that the AMP-activated protein kinase (AMPK) signaling pathway plays an important role in maintaining epithelial cell barrier function.

View Article and Find Full Text PDF

Immune checkpoint inhibitors for progressive multifocal leukoencephalopathy: a new gold standard?

J Neurol

July 2021

Sorbonne Université, AP-HP, Hôpitaux Universitaires Pitié-Salpêtrière Charles Foix, Institut Pierre Louis d'Épidémiologie et de Santé Publique, Service de Maladies Infectieuses et Tropicales, INSERM 1136, 47-83 Bd de l'Hôpital, 75651, Paris Cedex, France.

Objectives: Progressive multifocal leukoencephalopathy (PML) is a very rare and opportunistic encephalitis caused by JC polyomavirus that is linked to profound immunosuppression and is usually fatal unless immune function can be restored. Immune checkpoint inhibitors (ICI) are monoclonal antibodies (mAbs) that block either CTLA-4 or PD-1 inhibitor receptors, thus enhancing antiviral T-cell activity. Successful treatment of PML by ICI has recently generated some enthusiasm in case reports/small series of patients.

View Article and Find Full Text PDF

[médecine/sciences: 2021, resist, talk about research and move forward!].

Med Sci (Paris)

January 2021

Rédacteur en chef de médecine/sciences, Directeur de recherche émérite à l'Inserm Équipe « Microenvironnement immunitaire et immunothérapie », Centre d'immunologie et des maladies infectieuses (CIMI-Paris), Inserm UMRS 1135, Sorbonne université, 91 boulevard de l'Hôpital, 75013 Paris, France.

View Article and Find Full Text PDF

Natural killer cells in first-episode psychosis: an innate immune signature?

Mol Psychiatry

September 2021

Sorbonne Université, Inserm U1135, CNRS ERL 8255, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), F-75013, Paris, France.

Accumulating evidence majorly implicates immune dysfunction in the etiology of psychotic disorders. In particular, altered numbers and functions of natural killer (NK) cells have been described in psychosis, but interpretation has often been confounded by a number of biases, including treatment. Eighty-one first-episode psychosis (FEP) patients who subsequently received a diagnosis of either schizophrenia (SZ; n = 30) or bipolar disorder (BP; n = 31) over a five-year follow-up period were investigated for their NK cell phenotype and compared to 61 healthy controls (HCs).

View Article and Find Full Text PDF

IgA dominates the early neutralizing antibody response to SARS-CoV-2.

Sci Transl Med

January 2021

Sorbonne Université, Inserm, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), 91 boulevard de l'Hôpital, 75013 Paris, France.

Humoral immune responses are typically characterized by primary IgM antibody responses followed by secondary antibody responses associated with immune memory and composed of IgG, IgA, and IgE. Here, we measured acute humoral responses to SARS-CoV-2, including the frequency of antibody-secreting cells and the presence of SARS-CoV-2-specific neutralizing antibodies in the serum, saliva, and bronchoalveolar fluid of 159 patients with COVID-19. Early SARS-CoV-2-specific humoral responses were dominated by IgA antibodies.

View Article and Find Full Text PDF

The triggering receptor expressed on myeloid cells 1 (TREM-1) drives inflammatory responses in several cardiovascular diseases but its role in abdominal aortic aneurysm (AAA) remains unknown. Our objective was to explore the role of TREM-1 in a mouse model of angiotensin II-induced (AngII-induced) AAA. TREM-1 expression was detected in mouse aortic aneurysm and colocalized with macrophages.

View Article and Find Full Text PDF
Article Synopsis
  • * It analyzed clinical data from 29 KTR patients with severe onychomycosis, finding that over half had concerns about prescribing oral treatments due to altered renal parameters and lack of guidelines.
  • * Results showed that oral terbinafine was well-tolerated in KTR patients on different antirejection therapies, with only mild adverse events reported, suggesting its potential as a safe treatment option and the need for further research to create treatment guidelines.
View Article and Find Full Text PDF

Response to: 'Antirheumatic drugs, B cell depletion and critical COVID-19: correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine by Mathian ' by Notz .

Ann Rheum Dis

November 2022

Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Groupement Hospitalier Pitié-Salpêtrière, French National Referral Center for Systemic Lupus Erythematosus, Antiphospholipid Antibody Syndrome and Other Autoimmune Disorders, Service de Médecine Interne 2, Institut E3M, Inserm UMRS, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France.

View Article and Find Full Text PDF

[Therapeutic de-escalation in systemic lupus erythematosus in remission].

Rev Med Interne

December 2020

Sorbonne université, Assistance Publique-Hôpitaux de Paris, groupement hospitalier Pitié-Salpêtrière, Centre de Référence pour le Lupus, le Syndrome des anti-phospholipides et autres maladies auto-immunes rares, service de médecine Interne 2, institut E3M, Inserm UMRS, centre d'immunologie et des maladies infectieuses (CIMI-Paris), Paris, France. Electronic address:

View Article and Find Full Text PDF

Background: Interest for the study of gut mycobiota in relation with human health and immune homeostasis has increased in the last years. From this perspective, new tools to study the immune/fungal interface are warranted. Systemic humoral immune responses could reflect the dynamic relationships between gut mycobiota and immunity.

View Article and Find Full Text PDF